Atlas Trials

Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma

Clinical trial NCT01863108 · COMPLETED

Trial details

NCT number
NCT01863108
Sponsor
University Hospital, Grenoble
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
MelanomaTumor VaccinesEffects of Immunotherapy
Start date
2013-06-01
Primary completion
2017-03-23
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.